Global Antibody Drug Conjugates Contract Manufacturing Market Research Report 2022 - Market Study Report

Global Antibody Drug Conjugates Contract Manufacturing Market Research Report 2022

Report Format: PDF   |   Report ID: 5514202   |   Published Date: August 2022   |   Pages:  96  

Choose License
Highlights
The global Antibody Drug Conjugates Contract Manufacturing market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Antibody Drug Conjugates Contract Manufacturing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Antibody Drug Conjugates Contract Manufacturing in Solid Tumors is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Antibody Drug Conjugates Contract Manufacturing include Lonza Group, Piramal Pharma Solutions, Abbvie, Novasep, Merck, Cambrex Corporation, Recipharm, Thermo Fisher Scientific and Cerbios-Pharma, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, IgG1, which accounted for % of the global market of Antibody Drug Conjugates Contract Manufacturing in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of  % from 2022 to 2028. 
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibody Drug Conjugates Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Drug Conjugates Contract Manufacturing.
The Antibody Drug Conjugates Contract Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antibody Drug Conjugates Contract Manufacturing market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Drug Conjugates Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
    Lonza Group
    Piramal Pharma Solutions
    Abbvie
    Novasep
    Merck
    Cambrex Corporation
    Recipharm
    Thermo Fisher Scientific
    Cerbios-Pharma
    Sterling Pharma Solutions
    ADC Biotechnology
    Ajinomoto Bio-Pharma Services
    BOC Sciences
    BSP Pharmaceuticals
    CARBOGEN AMCIS
    Goodwin Biotechnology
Product Type Insights
Global markets are presented by Antibody Drug Conjugates Contract Manufacturing type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Antibody Drug Conjugates Contract Manufacturing are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Antibody Drug Conjugates Contract Manufacturing segment by Type
    IgG1
    IgG2
    IgG4
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Antibody Drug Conjugates Contract Manufacturing market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Antibody Drug Conjugates Contract Manufacturing market.
Antibody Drug Conjugates Contract Manufacturing Segment by Application
    Solid Tumors
    Hematological Malignancies
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antibody Drug Conjugates Contract Manufacturing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibody Drug Conjugates Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Antibody Drug Conjugates Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Antibody Drug Conjugates Contract Manufacturing industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibody Drug Conjugates Contract Manufacturing.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Drug Conjugates Contract Manufacturing companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 IgG1
        1.2.3 IgG2
        1.2.4 IgG4
    1.3 Market by Application
        1.3.1 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Solid Tumors
        1.3.3 Hematological Malignancies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Perspective (2017-2028)
    2.2 Antibody Drug Conjugates Contract Manufacturing Growth Trends by Region
        2.2.1 Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Region (2017-2022)
        2.2.3 Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2023-2028)
    2.3 Antibody Drug Conjugates Contract Manufacturing Market Dynamics
        2.3.1 Antibody Drug Conjugates Contract Manufacturing Industry Trends
        2.3.2 Antibody Drug Conjugates Contract Manufacturing Market Drivers
        2.3.3 Antibody Drug Conjugates Contract Manufacturing Market Challenges
        2.3.4 Antibody Drug Conjugates Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Antibody Drug Conjugates Contract Manufacturing Players by Revenue
        3.1.1 Global Top Antibody Drug Conjugates Contract Manufacturing Players by Revenue (2017-2022)
        3.1.2 Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Players (2017-2022)
    3.2 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Antibody Drug Conjugates Contract Manufacturing Revenue
    3.4 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio
        3.4.1 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugates Contract Manufacturing Revenue in 2021
    3.5 Antibody Drug Conjugates Contract Manufacturing Key Players Head office and Area Served
    3.6 Key Players Antibody Drug Conjugates Contract Manufacturing Product Solution and Service
    3.7 Date of Enter into Antibody Drug Conjugates Contract Manufacturing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Type
    4.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Type (2017-2022)
    4.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2023-2028)
5 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Application
    5.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Application (2017-2022)
    5.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size (2017-2028)
    6.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022)
    6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size (2017-2028)
    7.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022)
    7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size (2017-2028)
    8.2 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Antibody Drug Conjugates Contract Manufacturing Market Size (2017-2028)
    9.2 Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022)
    9.3 Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size (2017-2028)
    10.2 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Lonza Group
        11.1.1 Lonza Group Company Detail
        11.1.2 Lonza Group Business Overview
        11.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Introduction
        11.1.4 Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.1.5 Lonza Group Recent Development
    11.2 Piramal Pharma Solutions
        11.2.1 Piramal Pharma Solutions Company Detail
        11.2.2 Piramal Pharma Solutions Business Overview
        11.2.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction
        11.2.4 Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.2.5 Piramal Pharma Solutions Recent Development
    11.3 Abbvie
        11.3.1 Abbvie Company Detail
        11.3.2 Abbvie Business Overview
        11.3.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Introduction
        11.3.4 Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.3.5 Abbvie Recent Development
    11.4 Novasep
        11.4.1 Novasep Company Detail
        11.4.2 Novasep Business Overview
        11.4.3 Novasep Antibody Drug Conjugates Contract Manufacturing Introduction
        11.4.4 Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.4.5 Novasep Recent Development
    11.5 Merck
        11.5.1 Merck Company Detail
        11.5.2 Merck Business Overview
        11.5.3 Merck Antibody Drug Conjugates Contract Manufacturing Introduction
        11.5.4 Merck Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.5.5 Merck Recent Development
    11.6 Cambrex Corporation
        11.6.1 Cambrex Corporation Company Detail
        11.6.2 Cambrex Corporation Business Overview
        11.6.3 Cambrex Corporation Antibody Drug Conjugates Contract Manufacturing Introduction
        11.6.4 Cambrex Corporation Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.6.5 Cambrex Corporation Recent Development
    11.7 Recipharm
        11.7.1 Recipharm Company Detail
        11.7.2 Recipharm Business Overview
        11.7.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Introduction
        11.7.4 Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.7.5 Recipharm Recent Development
    11.8 Thermo Fisher Scientific
        11.8.1 Thermo Fisher Scientific Company Detail
        11.8.2 Thermo Fisher Scientific Business Overview
        11.8.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Introduction
        11.8.4 Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.8.5 Thermo Fisher Scientific Recent Development
    11.9 Cerbios-Pharma
        11.9.1 Cerbios-Pharma Company Detail
        11.9.2 Cerbios-Pharma Business Overview
        11.9.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Introduction
        11.9.4 Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.9.5 Cerbios-Pharma Recent Development
    11.10 Sterling Pharma Solutions
        11.10.1 Sterling Pharma Solutions Company Detail
        11.10.2 Sterling Pharma Solutions Business Overview
        11.10.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction
        11.10.4 Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.10.5 Sterling Pharma Solutions Recent Development
    11.11 ADC Biotechnology
        11.11.1 ADC Biotechnology Company Detail
        11.11.2 ADC Biotechnology Business Overview
        11.11.3 ADC Biotechnology Antibody Drug Conjugates Contract Manufacturing Introduction
        11.11.4 ADC Biotechnology Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.11.5 ADC Biotechnology Recent Development
    11.12 Ajinomoto Bio-Pharma Services
        11.12.1 Ajinomoto Bio-Pharma Services Company Detail
        11.12.2 Ajinomoto Bio-Pharma Services Business Overview
        11.12.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Introduction
        11.12.4 Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.12.5 Ajinomoto Bio-Pharma Services Recent Development
    11.13 BOC Sciences
        11.13.1 BOC Sciences Company Detail
        11.13.2 BOC Sciences Business Overview
        11.13.3 BOC Sciences Antibody Drug Conjugates Contract Manufacturing Introduction
        11.13.4 BOC Sciences Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.13.5 BOC Sciences Recent Development
    11.14 BSP Pharmaceuticals
        11.14.1 BSP Pharmaceuticals Company Detail
        11.14.2 BSP Pharmaceuticals Business Overview
        11.14.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Introduction
        11.14.4 BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.14.5 BSP Pharmaceuticals Recent Development
    11.15 CARBOGEN AMCIS
        11.15.1 CARBOGEN AMCIS Company Detail
        11.15.2 CARBOGEN AMCIS Business Overview
        11.15.3 CARBOGEN AMCIS Antibody Drug Conjugates Contract Manufacturing Introduction
        11.15.4 CARBOGEN AMCIS Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.15.5 CARBOGEN AMCIS Recent Development
    11.16 Goodwin Biotechnology
        11.16.1 Goodwin Biotechnology Company Detail
        11.16.2 Goodwin Biotechnology Business Overview
        11.16.3 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Introduction
        11.16.4 Goodwin Biotechnology Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022)
        11.16.5 Goodwin Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of IgG1 Table 3. Key Players of IgG2 Table 4. Key Players of IgG4 Table 5. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2017-2022) Table 9. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2023-2028) Table 11. Antibody Drug Conjugates Contract Manufacturing Market Trends Table 12. Antibody Drug Conjugates Contract Manufacturing Market Drivers Table 13. Antibody Drug Conjugates Contract Manufacturing Market Challenges Table 14. Antibody Drug Conjugates Contract Manufacturing Market Restraints Table 15. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players (2017-2022) Table 17. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2021) Table 18. Ranking of Global Top Antibody Drug Conjugates Contract Manufacturing Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Antibody Drug Conjugates Contract Manufacturing Product Solution and Service Table 22. Date of Enter into Antibody Drug Conjugates Contract Manufacturing Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2017-2022) Table 26. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2023-2028) Table 28. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2017-2022) Table 30. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Application (2023-2028) Table 32. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2023-2028) & (US$ Million) Table 42. Lonza Group Company Detail Table 43. Lonza Group Business Overview Table 44. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product Table 45. Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 46. Lonza Group Recent Development Table 47. Piramal Pharma Solutions Company Detail Table 48. Piramal Pharma Solutions Business Overview Table 49. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product Table 50. Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 51. Piramal Pharma Solutions Recent Development Table 52. Abbvie Company Detail Table 53. Abbvie Business Overview Table 54. Abbvie Antibody Drug Conjugates Contract Manufacturing Product Table 55. Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 56. Abbvie Recent Development Table 57. Novasep Company Detail Table 58. Novasep Business Overview Table 59. Novasep Antibody Drug Conjugates Contract Manufacturing Product Table 60. Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 61. Novasep Recent Development Table 62. Merck Company Detail Table 63. Merck Business Overview Table 64. Merck Antibody Drug Conjugates Contract Manufacturing Product Table 65. Merck Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 66. Merck Recent Development Table 67. Cambrex Corporation Company Detail Table 68. Cambrex Corporation Business Overview Table 69. Cambrex Corporation Antibody Drug Conjugates Contract Manufacturing Product Table 70. Cambrex Corporation Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 71. Cambrex Corporation Recent Development Table 72. Recipharm Company Detail Table 73. Recipharm Business Overview Table 74. Recipharm Antibody Drug Conjugates Contract Manufacturing Product Table 75. Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 76. Recipharm Recent Development Table 77. Thermo Fisher Scientific Company Detail Table 78. Thermo Fisher Scientific Business Overview Table 79. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product Table 80. Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 81. Thermo Fisher Scientific Recent Development Table 82. Cerbios-Pharma Company Detail Table 83. Cerbios-Pharma Business Overview Table 84. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product Table 85. Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 86. Cerbios-Pharma Recent Development Table 87. Sterling Pharma Solutions Company Detail Table 88. Sterling Pharma Solutions Business Overview Table 89. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product Table 90. Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 91. Sterling Pharma Solutions Recent Development Table 92. ADC Biotechnology Company Detail Table 93. ADC Biotechnology Business Overview Table 94. ADC Biotechnology Antibody Drug Conjugates Contract ManufacturingProduct Table 95. ADC Biotechnology Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 96. ADC Biotechnology Recent Development Table 97. Ajinomoto Bio-Pharma Services Company Detail Table 98. Ajinomoto Bio-Pharma Services Business Overview Table 99. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract ManufacturingProduct Table 100. Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 101. Ajinomoto Bio-Pharma Services Recent Development Table 102. BOC Sciences Company Detail Table 103. BOC Sciences Business Overview Table 104. BOC Sciences Antibody Drug Conjugates Contract ManufacturingProduct Table 105. BOC Sciences Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 106. BOC Sciences Recent Development Table 107. BSP Pharmaceuticals Company Detail Table 108. BSP Pharmaceuticals Business Overview Table 109. BSP Pharmaceuticals Antibody Drug Conjugates Contract ManufacturingProduct Table 110. BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 111. BSP Pharmaceuticals Recent Development Table 112. CARBOGEN AMCIS Company Detail Table 113. CARBOGEN AMCIS Business Overview Table 114. CARBOGEN AMCIS Antibody Drug Conjugates Contract ManufacturingProduct Table 115. CARBOGEN AMCIS Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 116. CARBOGEN AMCIS Recent Development Table 117. Goodwin Biotechnology Company Detail Table 118. Goodwin Biotechnology Business Overview Table 119. Goodwin Biotechnology Antibody Drug Conjugates Contract ManufacturingProduct Table 120. Goodwin Biotechnology Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) & (US$ Million) Table 121. Goodwin Biotechnology Recent Development Table 122. Research Programs/Design for This Report Table 123. Key Data Information from Secondary Sources Table 124. Key Data Information from Primary Sources List of Figures Figure 1. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Type: 2021 VS 2028 Figure 2. IgG1 Features Figure 3. IgG2 Features Figure 4. IgG4 Features Figure 5. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application in 2021 & 2028 Figure 6. Solid Tumors Case Studies Figure 7. Hematological Malignancies Case Studies Figure 8. Antibody Drug Conjugates Contract Manufacturing Report Years Considered Figure 9. Global Antibody Drug Conjugates Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Antibody Drug Conjugates Contract Manufacturing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region: 2021 VS 2028 Figure 12. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players in 2021 Figure 13. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue in 2021 Figure 15. North America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2017-2028) Figure 17. United States Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2017-2028) Figure 21. Germany Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2017-2028) Figure 29. China Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2017-2028) Figure 37. Mexico Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2017-2028) Figure 41. Turkey Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Lonza Group Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 44. Piramal Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 45. Abbvie Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 46. Novasep Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 47. Merck Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 48. Cambrex Corporation Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 49. Recipharm Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 51. Cerbios-Pharma Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 52. Sterling Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 53. ADC Biotechnology Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 54. Ajinomoto Bio-Pharma Services Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 55. BOC Sciences Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 56. BSP Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 57. CARBOGEN AMCIS Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 58. Goodwin Biotechnology Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2017-2022) Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us